An initial strategy of catheter ablation leads to a lower risk for a composite primary end point than antiarrhythmic drug ...

The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia. Treatment with landiolol resulted in ...

The usual first treatment to prevent dangerous episodes of ventricular tachycardia is anti-arrhythmia medications. However, these medications may have serious long-term side effects, such as ...

or sustained ventricular tachycardia terminated by emergency treatment. The participants were randomly assigned to open-label treatment with the antiarrhythmic drugs sotalol or amiodarone (with ...

Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

1 % in patients treated with placebo.” New Therapeutic option for rapid and “short-term” treatment of supraventricular tachycardia AOP Health strives to offer solutions for patients with rare diseases ...

Postural orthostatic tachycardia syndrome (POTS ... so that you can continue with the physical activity portion of treatment.

or sustained ventricular tachycardia terminated by emergency treatment) to receive antiarrhythmic drug therapy or to undergo catheter ablation. All the patients had an ICD. Catheter ablation was ...

The following is a summary of “Mortality in septic patients treated with short-acting betablockers: a comprehensive ...

The usual first treatment to prevent dangerous episodes of ventricular tachycardia is anti-arrhythmia medications. However, these medications may have serious long-term side effects, such as ...

Benign ventricular tachycardia (VT) in children usually ... Trials of an average 5.1 drugs/patient led to successful treatment in 6/8. Two others had a successful surgical cure.